BIZD is facing significant challenges due to rising non-accrual loans and record redemption requests exceeding $20 billion, which have led to gating measures and reduced management fees. This situation highlights liquidity stress across private credit and business development company (BDC) funds. The article recommends favoring actively managed BDC ETFs or high-quality, low-leverage BDCs like GLAD over indexed exposure through BIZD. Despite BIZD's convenience as an indexed option, sector-wide difficulties and risks of consolidation currently outweigh its benefits, leading to a Hold rating for BIZD.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Trupanion, a pet insurance provider, operates in the growing pet care market with subscription plans for cats and dogs. Despite a recent 2.68% dip, the stock has gained 4.13% over 30 days, indicating positive momentum and a potential buying opportuni...
Cass Information Systems reported strong first-quarter earnings of $0.66 per share, beating estimates, and achieved record annual net income of $35.1 million. The company is improving operational efficiency through automation and workforce reductions...
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
Citigroup lowered its price target for Ericsson to SEK 105 from SEK 110 and kept a Neutral rating after the company's Q2 2026 results missed revenue and earnings estimates. Ericsson's shares dropped over 13% due to rising component costs, especially ...
